
26 March 2025
Company Report | [SIDO IJ] Continuing To Widen Bottom-Line Margin, Higher Overseas Revenue, And Expand Into Younger Consumer Bases
FY24 Total Revenue achieved of 10% to IDR 3,919 bn. There was robust top-line growth across all revenue segments Herbal and Supplements with 6% YoY; Food and Beverages (18% YoY); and Pharmaceutical (10% YoY).